Go here to see the original:
CymaBay Therapeutics to Report Third Quarter 2020 Financial Results on Thursday, November 5, 2020
DBV Technologies Provides Update on Investigational Viaskin™ Peanut
Follow this link:
DBV Technologies Provides Update on Investigational Viaskin™ Peanut
Mesoblast Provides Update Following Meeting With FDA’s OTAT on Remestemcel-L for Children With Acute Graft Versus Host Disease
Ceapro Inc. to Present at the H.C. Wainwright BioConnect 2021 Virtual Conference
Pacific Biosciences of California, Inc. Fourth Quarter 2020 Financial Results Call
Generex Biotechnology Announces Investor Conference Call Scheduled for Friday February 5, 2021 at 9:00 AM
VALNEVA – Déclaration d’actions et de droits de vote – DECEMBRE 2020
Read the original:
VALNEVA - Déclaration d’actions et de droits de vote – DECEMBRE 2020
Vericel to Present at the 23rd Annual Needham Growth Conference on Friday, January 15, 2021
Sorrento Announces the Submission of a Marketing Authorization Application to COFEPRIS (Mexico) for COVI-STIX™ Rapid Detection Test of SARS-CoV-2…
Ascendis Pharma A/S Announces Equity Investment in VISEN Pharmaceuticals
Read this article:
Ascendis Pharma A/S Announces Equity Investment in VISEN Pharmaceuticals
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons
Auxly Announces Closing of $13.8 Million Bought-Deal Public Offering, Including Full Exercise of the Over-Allotment Option
Codiak BioSciences Reports Third Quarter 2020 Financial Results and Operational Progress
Golden Leaf Holdings Announces First Cashflow-Positive Quarter and Record Quarterly Revenues
Harrow Health Announces Participation at the Piper Sandler 32nd Annual Healthcare Conference
New Test for Triaging Preeclampsia Passes Key Development Milestone: Progenity Releases Prospective Clinical Verification Data for its Preecludia™…
Vericel Reports Record Third Quarter Revenues and Net Income
Summit Announces Closing of Private Placement of $50 Million
View original post here:
Summit Announces Closing of Private Placement of $50 Million
MHRA Grants HAE Patients Early Access to BioCryst’s Berotralstat in United Kingdom
Go here to see the original:
MHRA Grants HAE Patients Early Access to BioCryst’s Berotralstat in United Kingdom